Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anjum Hassan

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Experimental Hematology|January 13, 2009
Neurobeachin (NBEA) is a target of recurrent interstitial deletions at 13q13 in patients with MGUS and multiple myelomaJulie O'Neal, Feng Gao, Anjum Hassan, et al.
Acta Dermato-Venereologica|November 21, 2012
Cutaneous myeloid sarcoma: natural history and biology of an uncommon manifestation of acute myeloid leukemiaM Yadira Hurley, Grant K Ghahramani, Stephanie Frisch, et al.
Journal of Cutaneous Pathology|November 5, 2011
Use of classic and novel immunohistochemical markers in the diagnosis of cutaneous myeloid sarcomaCatalina Amador-Ortiz, Maria Y Hurley, Grant K Ghahramani, et al.
American Journal of Clinical Pathology|February 12, 2014
CD163 immunohistochemistry is superior to CD68 in predicting outcome in classical Hodgkin lymphomaJonathan L Klein, TuDung T Nguyen, Gabriel A Bien-Willner, et al.
Blood Advances|October 17, 2022
Distinct clonal identities of B-ALLs arising after lenolidomide therapy for multiple myelomaErica K Barnell, Zachary L Skidmore, Kenneth F Newcomer, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Experimental Hematology|January 13, 2009
Neurobeachin (NBEA) is a target of recurrent interstitial deletions at 13q13 in patients with MGUS and multiple myelomaJulie O'Neal, Feng Gao, Anjum Hassan, et al.
Acta Dermato-Venereologica|November 21, 2012
Cutaneous myeloid sarcoma: natural history and biology of an uncommon manifestation of acute myeloid leukemiaM Yadira Hurley, Grant K Ghahramani, Stephanie Frisch, et al.
Journal of Cutaneous Pathology|November 5, 2011
Use of classic and novel immunohistochemical markers in the diagnosis of cutaneous myeloid sarcomaCatalina Amador-Ortiz, Maria Y Hurley, Grant K Ghahramani, et al.
American Journal of Clinical Pathology|February 12, 2014
CD163 immunohistochemistry is superior to CD68 in predicting outcome in classical Hodgkin lymphomaJonathan L Klein, TuDung T Nguyen, Gabriel A Bien-Willner, et al.
Blood Advances|October 17, 2022
Distinct clonal identities of B-ALLs arising after lenolidomide therapy for multiple myelomaErica K Barnell, Zachary L Skidmore, Kenneth F Newcomer, et al.
Pageof 4